Want to see JP:3628 full AI Analyst Report?
Top Page
Data Horizon Co., Ltd.
(3628)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥639.00
▲(29.09% Upside)
Action:Reiterated
Date:07/14/26
The score is held back primarily by financial risk: very high leverage and negative/uneven cash flow despite improving revenue and a return to profitability. Technicals provide some support with the price above key moving averages, but mixed momentum (negative MACD) limits conviction. Valuation is only middling with a 27.6 P/E and no dividend yield data to offset risk.
Positive Factors
Steady Revenue Growth
Consistent revenue expansion indicates resilient demand and continued customer or market activity. If maintained, this growth provides a foundation for rebuilding earnings, supporting investment in the business, and improving operating leverage over the next several quarters.
Negative Factors
Very High Leverage
Very high leverage reduces financial flexibility and increases refinancing risk, leaving less capacity to fund growth or absorb weaker earnings. Because the equity base is small, earnings volatility can also produce sharp changes in leverage-related risk and financial resilience.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Consistent revenue expansion indicates resilient demand and continued customer or market activity. If maintained, this growth provides a foundation for rebuilding earnings, supporting investment in the business, and improving operating leverage over the next several quarters.
Read all positive factors
Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.11B
Dividend Yield0.39%
Average Volume (3M)11.65K
Price to Earnings (P/E)30.4
Beta (1Y)-0.03
Revenue Growth4.97%
EPS GrowthN/A
CountryJP
Employees365
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,711,780
10 Day Avg. Volume10,400
30 Day Avg. Volume11,650
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)13.29
Price to Sales (P/S)1.23
P/FCF Ratio-20.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Data Horizon Co., Ltd. Business Overview & Revenue Model
Company Description
Data Horizon Corporation offers specialized health data support solutions to insurance providers across Japan. The company develops and supplies medical information services, encompassing health-relevant data and notifications about generic drugs,...
Data Horizon Co., Ltd. Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
24
Negative
Cash Flow
27
Negative
| Breakdown | TTM | Mar 2026 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.14B | 5.14B | 5.14B | 5.01B | 4.41B | 2.99B |
| Gross Profit | 1.32B | 1.79B | 2.07B | 1.90B | 1.18B | 1.44B |
| EBITDA | 82.80M | 387.70M | 82.80M | -148.66M | -1.59M | -136.32M |
| Net Income | -3.95B | 268.00M | -3.95B | -807.18M | -664.86M | -410.80M |
Balance Sheet | ||||||
| Total Assets | 7.79B | 8.36B | 7.79B | 7.90B | 7.44B | 2.26B |
| Cash, Cash Equivalents and Short-Term Investments | 1.22B | 1.02B | 1.22B | 1.42B | 1.08B | 379.98M |
| Total Debt | 4.81B | 5.29B | 4.81B | 2.46B | 1.47B | 400.00M |
| Total Liabilities | 7.57B | 7.88B | 7.57B | 4.68B | 3.42B | 977.21M |
| Stockholders Equity | 221.67M | 476.48M | 221.67M | 3.19B | 3.97B | 1.26B |
Cash Flow | ||||||
| Free Cash Flow | -154.63M | -309.73M | -1.89B | 64.81M | -253.54M | -747.41M |
| Operating Cash Flow | -145.58M | -219.34M | -1.88B | 120.13M | -198.37M | -442.98M |
| Investing Cash Flow | -177.67M | -797.68M | -673.71M | -789.14M | -3.51B | -572.80M |
| Financing Cash Flow | 410.07M | 809.00M | 2.35B | 1.02B | 4.41B | 331.20M |
Data Horizon Co., Ltd. Technical Analysis
Positive
495.00
Price Trends
576.72
Positive
559.19
Positive
533.94
Positive
Market Momentum
15.98
Negative
69.08
Neutral
82.96
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Positive. The current price of 495 is below the 20-day moving average (MA) of 599.60, below the 50-day MA of 576.72, and below the 200-day MA of 533.94, indicating a bullish trend. The MACD of 15.98 indicates Negative momentum. The RSI at 69.08 is Neutral, neither overbought nor oversold. The STOCH value of 82.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3628.
Data Horizon Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥1.22T | 26.06 | 11.45% | 1.29% | 15.76% | 13.53% | |
71 Outperform | ¥233.97B | 33.75 | ― | 0.50% | 18.89% | 11.66% | |
59 Neutral | ¥81.20B | 42.47 | 12.35% | 0.00% | 24.03% | 34.50% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥8.11B | 30.40 | ― | 0.39% | 4.97% | ― | |
46 Neutral | ¥2.26B | -4.29 | ― | ― | 14.84% | 30.67% |
* Healthcare Sector Average
JP:3628
Data Horizon Co., Ltd.
666.00
145.00
27.83%
JP:2413
M3
1,703.50
-681.28
-28.57%
JP:4480
Medley
2,427.00
-35.00
-1.42%
JP:4438
Welby Inc.
261.00
-72.00
-21.62%
JP:4483
JMDC Inc.
3,590.00
-805.62
-18.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.